APRIL GILES: Open Payments
NPI 1447761952 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 51 payments from 14 companies in 2025. Trend: 2023 $555 · 2024 $1,213 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $400 |
| ABBVIE INC. | 14 | $190 |
| PFIZER INC. | 10 | $141 |
| Novo Nordisk Inc | 3 | $72 |
| Amgen Inc. | 3 | $66 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: FARXIGA, BREZTRI, NURTEC ODT, VRAYLAR, AIRSUPRA, KRYSTEXXA, Rybelsus, UBRELVY.
Industry payments across VA — which companies pay providers there.
